Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

43
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
43
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

29
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
29
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

298
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
298
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

44
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
44
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

30
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
30
Depression: Overview01:18

Depression: Overview

208
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facial Expression Metrics as Digital Biomarkers of Neurologic Disease.

Neurology open access·2026
Same author

Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.

Journal of neurology·2026
Same author

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.

Lancet (London, England)·2026
Same author

Large language models to infer depression in patients with neurological conditions.

BMJ neurology open·2026
Same author

Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.

Neurodegenerative disease management·2026
Same author

Closing the referral gap: The role of a quality improvement initiative to enhance pelvic health physical therapy referrals for persons with multiple sclerosis-related bladder symptoms.

Multiple sclerosis journal - experimental, translational and clinical·2026

Related Experiment Video

Updated: May 27, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K

Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study (P4-6.014).

Madeleine Rose1, Stephanie Hsu1, Ayushi Balan1

  • 1University of California, San Francisco.

Neurology
|February 20, 2025
PubMed
Summary

Peripartum depression affects nearly 20% of women with multiple sclerosis (MS), peaking at one month postpartum. Early evaluation and integrated care are crucial for managing mood concerns in pregnant and postpartum individuals with MS.

More Related Videos

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

24.7K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K

Related Experiment Videos

Last Updated: May 27, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

24.7K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K

Area of Science:

  • Neurology
  • Psychiatry
  • Women's Health

Background:

  • Women with neurological conditions, including multiple sclerosis (MS), face elevated risks for peripartum depression and anxiety.
  • The interplay between mood disorders and the postpartum clinical course of MS remains underexplored.

Purpose of the Study:

  • To determine the prevalence and timing of perinatal depression and anxiety in women with MS.
  • To identify risk factors associated with peripartum mood disturbances in this population.

Main Methods:

  • Prospective registry (PRISMA) of women with MS who are pregnant, postpartum, or planning pregnancy.
  • Analysis of data from 53 participants, including structured depression assessments (MINI/SCID) and serial surveys (EPDS, HADS, Epworth Sleepiness Scale).

Main Results:

  • The prevalence of depression within the first year postpartum was 19.51%.
  • The highest incidence of elevated depressive symptoms (EPDS scores ≥ 10) occurred at 1 month postpartum (19%), with most cases resolving by 4 months.
  • Postpartum depressive symptoms correlated with anxiety scores and were associated with a history of psychiatric disease, but not with MRI findings or postpartum relapses.

Conclusions:

  • The 19.5% prevalence of postpartum depression in women with MS exceeds that of the general population, underscoring the need for targeted screening.
  • The peak incidence of mood concerns at 1 month postpartum highlights the critical window for early intervention and integrated care.
  • A history of psychiatric illness is a significant risk factor, while MS-specific clinical or radiological activity did not correlate with postpartum mood issues in this cohort.